Skip to main content
    M

    Mind Medicine Inc (MNMD)

    Official site

    BIOTECHNOLOGY

    $15.02
    +0.15 (+1.01%)

    Last updated: Jan 14, 2026 at 4:00 PM ET

    Mind Medicine Inc (MNMD) Financials: Revenue, Profit and Cash Flow

    Updated Nov 6, 2025. Financial statements from company filings, amounts in US dollars.

    Mind Medicine reported revenue of $0 for the fiscal year ended Dec 31, 2024. That year, net income was -$108.68M, operating cash flow was -$79.13M and free cash flow was -$79.13M. The quarter ended Sep 30, 2025 had revenue of $0 and net income of -$67.27M.

    Revenue and Margins

    The company reported no revenue in the fiscal year ended Dec 2024, with an operating loss of $103.92M.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2024$0N/AN/AN/AN/A
    Dec 2023$0N/AN/AN/AN/A
    Dec 2022$0N/AN/AN/AN/A
    Dec 2021$0N/AN/AN/AN/A
    Dec 2020$0N/AN/AN/AN/A
    Dec 2019N/AN/AN/AN/AN/A
    Dec 2018N/AN/AN/AN/AN/A
    Dec 2017N/AN/AN/AN/AN/A
    Dec 2016N/AN/AN/AN/AN/A
    Dec 2015N/AN/AN/AN/AN/A
    Annual, fiscal years ended Dec 2015 to Dec 2024

    Income Statement

    In the fiscal year ended Dec 2024, the net loss widened from the year before. In the quarter ended Sep 2025, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015
    Cost of revenue$527.00K$3.16M$3.22M$2.62MN/AN/AN/AN/AN/AN/A
    Gross profit-$527.00K-$3.16M-$3.22M-$2.62MN/AN/AN/AN/AN/AN/A
    Research and development$65.30M$48.96M$36.17M$34.79M$18.63M$0$0$0$0$0
    Operating income-$103.92M-$93.87M-$66.33M-$93.85M-$33.03M-$468.18K-$861.94K-$1.24M-$111.25K-$94.55K
    Net income-$108.68M-$95.73M-$56.80M-$93.04M-$34.10M-$1.12M-$857.94K-$1.23M-$179.90K-$92.66K
    EBITDAN/A-$92.57M-$63.15M-$91.24M-$32.29MN/A-$851.26KN/A-$111.25K-$92.66K
    Fiscal years ended Dec 2015 to Dec 2024

    Quarterly

    Line itemSep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022
    Revenue$0$0$0$0$0$0$0$4.84M$0$0$0$0
    Gross profitN/AN/AN/AN/AN/AN/A-$527.00K$4.05M-$800.00K-$814.00K-$805.00K-$803.00K
    Operating income-$45.67M-$40.90M-$32.16M-$32.46M-$24.79M-$24.46M-$22.20M-$22.20M-$21.62M-$29.18M-$20.86M-$13.90M
    Net income-$67.27M-$42.74M-$23.35M-$34.74M-$13.68M-$5.85M-$54.40M-$23.86M-$17.92M-$29.13M-$24.82M-$4.90M
    Last 12 quarters

    Balance Sheet

    As of Dec 2024, cash and equivalents exceeded long-term debt of $21.85M by $251.89M.

    Annual

    Line itemDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015
    Total assets$302.15M$124.54M$169.99M$164.00M$81.52M$2.94M$3.53M$4.03M$202.75K$291.66K
    Current assets$281.62M$103.87M$146.06M$137.22M$81.52M$2.94M$198.63K$1.77M$136.19K$186.40K
    Cash and equivalents$273.74M$99.70M$142.14M$133.54M$80.09M$17.93K$154.79KN/A$10.96KN/A
    Total liabilities$60.70M$46.41M$19.08M$12.34M$5.65M$198.96KN/A$80.44K$75.47KN/A
    Short-term debtN/AN/A$72.00KN/AN/AN/AN/A$15.74KN/AN/A
    Long-term debt$21.85M$14.13MN/AN/AN/AN/AN/AN/AN/AN/A
    Shareholder equity$241.45M$78.13M$150.92M$151.66M$75.87M$2.74M$3.52M$3.95M$127.28K$284.17K
    Fiscal years ended Dec 2015 to Dec 2024

    Quarterly

    Line itemSep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022
    Total assets$236.92M$265.09M$275.32M$302.15M$319.77M$268.14M$275.53M$124.54M$141.55M$142.09M$155.53M$169.99M
    Total liabilities$106.32M$79.69M$52.52M$60.70M$57.58M$66.10M$79.47M$46.41M$45.57M$36.11M$25.18M$19.08M
    Cash and equivalents$19.96M$33.39M$82.85M$273.74M$295.28M$243.13M$252.33M$99.70M$117.70M$116.89M$129.41M$142.14M
    Shareholder equity$130.60M$185.40M$222.81M$241.45M$262.19M$202.05M$196.06M$78.13M$95.98M$105.97M$130.34M$150.92M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2024.

    Annual

    Line itemDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015
    Operating cash flow-$79.13M-$64.36M-$50.14M-$45.82M-$23.60M-$208.12K-$722.45K-$665.98K-$26.64K-$46.56K
    Capital expenditures$0$0$0$0$0$313.46K$1.04M$2.15M$30.10K$0
    Free cash flow-$79.13M-$64.36M-$50.14M-$45.82M-$23.60M-$521.58K-$1.77M-$2.82M-$56.73K-$46.56K
    Investing cash flowN/AN/AN/A-$297.00K-$297.00K-$213.15K$541.34K-$3.67M$32.83K$41.86K
    Financing cash flow$253.20M$21.85M$59.05M$98.82M$96.70M$288.36K$312.05K$4.35MN/AN/A
    Fiscal years ended Dec 2015 to Dec 2024

    Quarterly

    Line itemSep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022
    Operating cash flow-$29.57M-$29.60M-$29.42M-$25.35M-$17.19M-$19.99M-$16.60M-$20.56M-$16.63M-$13.85M-$13.33M-$12.85M
    Free cash flow-$29.57MN/A-$29.42M-$25.35MN/AN/A-$16.60M-$20.56M-$16.63M-$13.85M-$13.33M-$12.85M
    Last 12 quarters

    Frequently Asked Questions About MNMD

    What is Mind Medicine's annual revenue?

    Mind Medicine reported revenue of $0 for the fiscal year ended Dec 31, 2024.

    Is Mind Medicine profitable?

    No. Mind Medicine reported net income of -$108.68M for the fiscal year ended Dec 31, 2024.

    How much free cash flow does MNMD generate?

    For the fiscal year ended Dec 31, 2024, operating cash flow of -$79.13M minus capital expenditures of $0 produced free cash flow of -$79.13M.

    How much debt does Mind Medicine have?

    The balance sheet dated Dec 31, 2024 reported long-term debt of $21.85M and cash and equivalents of $273.74M.